Functional Committee - Audit Committee

Audit Committee 
The Audit Committee  of ICP DAS was established on Jun 14, 2022.
The Committee is composed of all independent directors. The Committee  shall consist of at least three members.
Term of Office of the Second Committee Members: 2025 / 06 / 19 ~ 2028 / 06 / 18 , with 4 Committee members.
Members of the Second Audit Committee
Independent Director  SHOU-HUNG HSUEH
 Independent Director SHAO-CHI CHEN 
Independent Director YU CHAO
Independent Director SHIH-YI LIN
 
For information on each member’s attendance at Committee meetings, please refer to ICP DAS’s annual reports.
 
Year Item  \  Name YANG-BIN
 SHEN 
 YI-JYUN
JIANG 
 SHAO-CHI
CHEN
YU
CHAO 
SHOU-HUNG
HSUEH
 SHIH-YI
LIN
2024 Actual Attendance 4 4 4 4 - -
Attendance by Proxy 0 0 0 0 - -
Attendance Rate 100% 100% 100% 100% NA NA
2025 Actual Attendance 2 2 4 4 2 2
Attendance by Proxy 0 0 0 0 0 0
Attendance Rate 100% 100% 100% 100% 100% 100%
 
Date Content The Resolutions
2024/03/04 1. 2023 Annual Business Report, Consolidated Financial Report, and Parent Company Only Financial Report.
2.The 2023 Surplus earnings distribution proposal.
3.Independent evaluation and proposals of appointment and  remuneration for accountants in 2024.
4. Related party transactions.
5. Issuance of the 2023 Annual Statement of Internal Control System and evaluation of its effectiveness.
All members of the Committee agreed and approved
The five agenda item was approved by resolution at the first Board of Directors meeting in 2024.
2024/05/09 1.Discussion to approve the 2024 Q1 Consolidated Financial Report.
2. Amendment of “Audit Committee Charter ”.
3. Related party transactions.
All members of the Committee agreed and approved
The three agenda item was approved by resolution at the second Board of Directors meeting in 2024.
2024/08/06 1.Discussion to approve the 2024 Q2 Consolidated Financial Report.
2. Related party transactions.
All members of the Committee agreed and approved
The two agenda item was approved by resolution at the fourth Board of Directors meeting in 2024.
2024/11/05 1.Discussion to approve the 2024 Q3 Consolidated Financial Report.
2.Related party transactions.
3.Disposal of the Company's 18% stake in ICP DAS EUROPE GMBH.
4.Amendment of “Internal Control System” and “Internal Audit System.”

5.Discussion of Prescribe to the 2025 audit plan.
All members of the Committee agreed and approved
The five agenda item was approved by resolution at the fifth Board of Directors meeting in 2024.
2025/03/06 1. 2024 Annual Business Report, Consolidated Financial Report, and Parent Company Only Financial Report.
2.The 2024 Surplus earnings distribution proposal.

3.Discussion of amendments to the Company's "Procedures for Asset Acquisition & Disposal".
4. Discussion of lifting non-competition restrictions on new directors and their representatives.
5. Proposal for the Rotation of Certified Public Accountants (CPAs).

6.Independent evaluation and proposals of appointment and  remuneration for accountants in 2025.
7. Issuance of the 2024 Annual Statement of Internal Control System and evaluation of its effectiveness.
All members of the Committee agreed and approved
The seven agenda item was approved by resolution at the second Board of Directors meeting in 2025.
2025/05/02 1.Discussion to approve the 2025 Q1 Consolidated Financial Report.
2.Confirmation of the nomination of director candidates.
3. Discussion of lifting non-competition restrictions on the nomination of director  candidates.
4.Amendment of “Audit Committee Charter ”.
All members of the Committee agreed and approved
The four agenda item was approved by resolution at the third Board of Directors meeting in 2025.
2025/06/19 The proposal for the Nomination of the Chairperson for the Second Audit Committee. All members of the Committee agreed to appoint Member SHOU-HUNG HSUEH as the Chairperson of the second Audit Committee.
2025/08/05 1.Discussion to approve the 2025 Q2 Consolidated Financial Report. All members of the Committee agreed and approved
The agenda item was approved by resolution at the fifth Board of Directors meeting in 2025.